menu
    • menu

    Company profile for EsoBiotec

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EsoBiotec is a biotech company revolutionizing adoptive cell therapy with off-the-shelf, immune-shielded, and cost-effective solutions to simplify cancer treatment. Their mission is to make cancer therapies more accessible, effective, and affordable by engineering immune cells directly within the patient's body. This approach eliminates the challenges of traditional cell therapies, offering new possibilities for treating solid...
    EsoBiotec is a biotech company revolutionizing adoptive cell therapy with off-the-shelf, immune-shielded, and cost-effective solutions to simplify cancer treatment. Their mission is to make cancer therapies more accessible, effective, and affordable by engineering immune cells directly within the patient's body. This approach eliminates the challenges of traditional cell therapies, offering new possibilities for treating solid tumors and autoimmune diseases. EsoBiotec is committed to transforming cancer treatment for patients and healthcare providers worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EsoBiotecBelgium Flag
    Country
    Country
    Belgium
    Address
    Address
    Rue André Dumont 5, Mont-Saint-Guibert, 6041 Charleroi
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.esobiotec.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Astrazeneca In Vivo Data Shows Potential, Despite Patient Death
    Astrazeneca In Vivo Data Shows Potential, Despite Patient Death

    28 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astrazenecas-vivo-car-t-bet-eradicates-cancer-3-5-patients-death-mars-dataset

    FIERCE BIOTECH
    28 Mar 2026
    Share Share
    EsoBiotec to Present Data at ASGCT Annual Meeting
    EsoBiotec to Present Data at ASGCT Annual Meeting

    29 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/29/3070036/0/en/EsoBiotec-to-Present-Preclinical-Proof-of-Concept-Data-for-Its-Off-the-Shelf-ENaBL-In-Vivo-Cell-Therapy-Platform-at-the-28th-Annual-Meeting-of-the-American-Society-of-Gene-and-Cell.html

    GLOBENEWSWIRE
    29 Apr 2025
    Share Share
    AstraZeneca boosts cancer therapies with $1B EsoBiotec buy
    AstraZeneca boosts cancer therapies with $1B EsoBiotec buy

    17 Mar 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/astrazeneca-buy-esobiotec-upto-1-billion-2025-03-17/

    REUTERS
    17 Mar 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search